Botulinum Toxin in Burning Mouth Syndrome

Status Completed

Clinical Trial Summary

The effect of botulinum neurotoxin type A intradermal injection in will be evaluated in 4 patients with clinical diagnosis of burning mouth syndrome involving the anterior two-thirds of the tongue and the lower lip for at least 6 months, refractory to common pharmacological treatments. Pain severity will be measured by the visual analog scale (VAS) indicating average week pain before injection. Each patient will be injected with a total dose of 16 units (dilution: 2 ml saline) of incobotulinumA: 4 units into each side of the lower lip and 4 units into each antero-lateral side of the tongue. In order to determine if a placebo effect may be involved, we will inject 2 additional patients with saline solution using the same volumes and the same injection sites. Patients will be evaluated at 48 hours and then at 4, 8, 12, 16 and 20 weeks after the treatment. Patients treated with placebo will be treated after 4 weeks with incobotulinumA with the same dose reported above.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02964728
Study type	Interventional
Source	Presidio Ospedaliero Garibaldi-Centro
Contact
Status	Completed
Phase	Phase 2
Start date	November 2015
Completion date	May 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04475614` - Therapeutic Options for Treatment of Burning Mouth Syndrome	N/A
Completed	`NCT00374673` - Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders	Phase 3
Completed	`NCT04535973` - Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
Recruiting	`NCT06040190` - Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome	Phase 4
Not yet recruiting	`NCT05059418` - Burning Mouth Syndrome - New Diagnostic Criteria and Treatment	N/A
Recruiting	`NCT01867151` - Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome	N/A
Completed	`NCT05872789` - Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome	N/A
Completed	`NCT05871580` - Effect to the Photobiomodulation in the Burning Mouth Syndrome	N/A
Recruiting	`NCT05309070` - The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome	N/A
Completed	`NCT05399238` - Thermography and Burning Mouth Syndrome
Completed	`NCT02382029` - Acupuncture Versus Clonazepam in Burning Mouth Syndrome	Phase 0
Completed	`NCT02580734` - Efficacy of Melatonin in Burning Mouth Syndrome (BMS)	N/A
Recruiting	`NCT05819697` - Reducing Patient Memory Recall in the Burning Mouth Patient Population
Completed	`NCT02757612` - Study Evaluating the Laser Diode Effect Burning Mouth Syndrome	N/A
Completed	`NCT00862576` - A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome	N/A
Not yet recruiting	`NCT04189367` - Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine	Phase 3
Completed	`NCT00001524` - Thalidomide to Treat Oral Lesions in HIV-Infected Patients	Phase 2
Recruiting	`NCT04481841` - Head Yuanshi Dian Therapy in Burning Mouth Syndrome	Early Phase 1
Completed	`NCT02686359` - Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)	N/A
Completed	`NCT05309681` - Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome